Skip to main content
. 2018 Nov 14;38(6):BSR20181213. doi: 10.1042/BSR20181213

Figure 1. Down-regulation of plasma lncRNA snaR effectively distinguished HPV-negative CSCC patients from healthy controls.

Figure 1

Plasma lncRNA snaR was significantly down-regulated in HPV-negative CSCC patients than in healthy controls (A) and the down-regulation of plasma lncRNA snaR effectively distinguished HPV-negative CSCC patients from healthy controls (B) (*P<0.05).